This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Innovations of Dong Shan An in Ginsenoside Glycosidase Protein
Introduction
Dong Shan An is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of novel proteins that enhance the bioavailability of ginsenosides. His work focuses on the conversion of protopanaxadiol (PPD)-type saponins into more active and absorbable forms.
Latest Patents
Dong Shan An holds a patent related to a novel ginsenoside glycosidase protein derived from a specific genus. This protein exhibits the ability to convert PPD-type saponins into highly active substances through selective hydrolysis of particular bonds in ginsenosides. The patent encompasses an amino acid sequence of the protein, a nucleic acid sequence encoding the protein, and a recombinant vector that includes the nucleic acid sequence. Additionally, it describes a method for producing ginsenoside glycosidase by culturing a transformant, as well as a composition for converting PPD-type saponins into soluble forms.
Career Highlights
Dong Shan An is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His research has led to advancements in the understanding and application of ginsenoside glycosidase proteins, which have potential implications in health and nutrition.
Collaborations
He has collaborated with notable colleagues such as Song Gun Kim and Sung Taik Lee, contributing to the advancement of research in his field.
Conclusion
Dong Shan An's innovative work in ginsenoside glycosidase proteins represents a significant advancement in biotechnology. His contributions have the potential to enhance the efficacy of ginsenosides, paving the way for new applications in health and wellness.